Sun Pharma Advanced Research Company (SPARC) has surged 5% to Rs 151, extending its previous day’s 15% rally, after reporting net profit of Rs 44 crore for the fourth quarter ended March 31, 2013 on back of healthy growth in operational income.
The company engaged pharmaceutical research and development had loss of Rs 21.58 crore in year a ago quarter.
“Income from operations rose 1602% to Rs 71.83 crore in the quarter ended March 2013 as against Rs 4.22 crore during the previous quarter ended March 2012,” SPARC said in a statement.
For the full financial year 2012-13, net loss of the company more than halved to Rs 22.49 crore as against net loss of Rs 72.22 crore during the previous year ended March 2012.
The stock opened at Rs 154 and touched 52-week high of Rs 157 on NSE. A combined 1.9 million shares changed hands on the counter till early morning deals against sub 100,000 shares that were traded daily in past two weeks on NSE and BSE.
The company engaged pharmaceutical research and development had loss of Rs 21.58 crore in year a ago quarter.
“Income from operations rose 1602% to Rs 71.83 crore in the quarter ended March 2013 as against Rs 4.22 crore during the previous quarter ended March 2012,” SPARC said in a statement.
For the full financial year 2012-13, net loss of the company more than halved to Rs 22.49 crore as against net loss of Rs 72.22 crore during the previous year ended March 2012.
The stock opened at Rs 154 and touched 52-week high of Rs 157 on NSE. A combined 1.9 million shares changed hands on the counter till early morning deals against sub 100,000 shares that were traded daily in past two weeks on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%